GLP-1 / Glucagon dual receptor agonist. Lyophilized.
In Stock
Mazdutide is a synthetic peptide that acts as a dual agonist of the GLP-1 and glucagon receptors, structurally derived from oxyntomodulin.
It has been characterised in preclinical metabolic-research literature as a reference dual-incretin compound.
Lyophilized under inert atmosphere. Reconstitute with sterile bacteriostatic water; store reconstituted samples refrigerated. For laboratory and research use only. Not for human or veterinary use.
Every batch of Mazdutide is independently tested by a third-party laboratory. Certificates of Analysis include HPLC purity testing, mass spectrometry confirmation, and sterility verification.
Contact us at info@spartalabs.net to request the COA for this product.
Orders are processed within 1–2 business days. Standard shipping typically takes 3–5 business days within the continental United States.
All products are shipped in temperature-controlled, discreet packaging to ensure product integrity.
Mazdutide is a synthetic peptide that acts as a dual agonist of the GLP-1 and glucagon receptors, structurally derived from oxyntomodulin.
It has been characterised in preclinical metabolic-research literature as a reference dual-incretin compound.
Lyophilized under inert atmosphere. Reconstitute with sterile bacteriostatic water; store reconstituted samples refrigerated. For laboratory and research use only. Not for human or veterinary use.
How SpartaLabs sources, tests, and verifies mazdutide for research applications, including synthesis standards, HPLC purity, and third-party COA verification. Educational reference.
A bibliographic summary of published clinical and preclinical research on mazdutide (IBI362 / LY3305677), spanning phase 1b through phase 3 trial programs and mechanistic investigations. Educational reference.
A research-library overview of mazdutide (IBI362 / LY3305677) — chemistry, classification, pharmacological properties, and regulatory history as the world's first approved dual GCG/GLP-1 receptor agonist. Educational reference.
A research-library examination of mazdutide's reported mechanism of action at the GLP-1 and glucagon receptors, including molecular binding, cAMP signaling, and downstream effects documented in primary literature. Educational reference.
A research-library account of mazdutide's scientific lineage, from foundational incretin and oxyntomodulin research through clinical development milestones and China NMPA regulatory approvals. Educational reference.
Peptide0.9% Benzyl Alcohol Preserved Water. Sterile. 10ml vial.
PeptideBacteriostatic Water for Research. Sterile. 10ml vial.
PeptideTetra-substituted GHRH analogue with Drug Affinity Complex. Lyophilized.
PeptideCo-lyophilized 10 mg BPC-157 / 10 mg TB-500. ≥ 99% purity.
PeptideFour-peptide blend: GHK-Cu, TB-500, BPC-157, KPV. 80 mg total. Lyophilized.
PeptideCo-lyophilized 5 mg BPC-157 / 5 mg TB-500. ≥ 99% purity.
PeptideSynthetic hexapeptide ghrelin-receptor agonist. Lyophilized.
PeptideSynthetic tetrapeptide (Ala-Glu-Asp-Gly). Lyophilized.
PeptideSynthetic pentadecapeptide. Lyophilized. ≥ 99% purity.
PeptideLong-acting amylin analogue. Lyophilized. ≥ 99% purity.
PeptideTetra-substituted GHRH (1-29) analogue, no DAC. Lyophilized. ≥ 99% purity.
PeptideModified C-terminal fragment (Tyr-hGH 177-191) of human growth hormone. Lyophilized.
No reviews yet. Be the first verified buyer to share your experience from your account → orders page after your shipment arrives.
Reviews are open to verified buyers from your account → orders page. Every submission is moderated for compliance — we filter human-use and medical claims evenhandedly across positive and negative reviews. See our review moderation policy for the exact rules and 1–2 business-day review window.
